Tinavi Medical Technologies Co Ltd Tangible Net Worth Ratio
Tinavi Medical Technologies Co Ltd tangible net worth ratio. Tinavi Medical Technologies Co Ltd (688277) has a Tangible Net Worth Ratio of 95.0% as of March 2026. This metric is calculated by deducting intangible assets (CN¥59.07 Million) from net assets (CN¥1.19 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 688277 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Tinavi Medical Technologies Co Ltd (2013–2025)
Tangible net worth ratio of Tinavi Medical Technologies Co Ltd from 2013 to 2025. This chart shows how Tinavi Medical Technologies Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 95.0%, reflecting net assets of CN¥1.19 Billion with intangible assets of CN¥59.07 Million CNY. See 688277 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tinavi Medical Technologies Co Ltd Tangible Net Worth Ratio by Year (2013–2025)
Tinavi Medical Technologies Co Ltd tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Tinavi Medical Technologies Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 688277 company net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.2% | CN¥3.01 Billion | CN¥54.17 Million | CN¥1.71 Billion | ▲ +1.7 pp |
| 2024 | 96.5% | CN¥1.28 Billion | CN¥45.17 Million | CN¥1.69 Billion | ▼ -2.1 pp |
| 2023 | 98.6% | CN¥1.24 Billion | CN¥17.23 Million | CN¥1.62 Billion | ▼ -0.8 pp |
| 2022 | 99.4% | CN¥1.12 Billion | CN¥6.69 Million | CN¥1.41 Billion | ▲ +0.1 pp |
| 2021 | 99.3% | CN¥1.07 Billion | CN¥7.61 Million | CN¥1.28 Billion | ▼ -0.1 pp |
| 2020 | 99.4% | CN¥1.03 Billion | CN¥6.26 Million | CN¥1.12 Billion | ▼ -0.2 pp |
| 2019 | 99.5% | CN¥596.34 Million | CN¥2.73 Million | CN¥713.60 Million | ▼ -0.1 pp |
| 2018 | 99.7% | CN¥560.61 Million | CN¥1.73 Million | CN¥662.66 Million | ▲ +0.0 pp |
| 2017 | 99.7% | CN¥169.41 Million | CN¥535.50K | CN¥622.67 Million | ▼ -0.1 pp |
| 2016 | 99.8% | CN¥136.62 Million | CN¥271.54K | CN¥185.77 Million | ▲ +0.2 pp |
| 2015 | 99.6% | CN¥203.98 Million | CN¥868.91K | CN¥211.96 Million | ▲ +2.3 pp |
| 2014 | 97.3% | CN¥52.84 Million | CN¥1.42 Million | CN¥67.09 Million | ▲ +4.5 pp |
| 2013 | 92.8% | CN¥29.60 Million | CN¥2.13 Million | CN¥41.36 Million | — |